Can residual leg shortening be predicted in patients with Legg-Calvé-Perthes' disease? Pediatrics

Kwang Won Park, Kyu Seon Jang, Hae Ryong Song

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Although Legg-Calvé-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified. Questions/purposes: We attempted to determine whether (1) the extent of femoral head involvement; (2) varus osteotomy; and (3) patient demographic characteristics are associated with LLD at skeletal maturity in patients with LCPD. Methods: We retrospectively reviewed the records of 168 skeletally mature patients with unilateral LCPD. The mean age at diagnosis was 7 years (range, 2-14 years). The extent of femoral head involvement was determined from the initial radiographs using the Herring lateral pillar and Catterall classifications. LLD was defined as shortening by ≥ 1.0 cm as measured from scanograms. The patient's sex and the treatment modalities used were also recorded. Results: LLD ranging from 10 to 38 mm (mean, 19 mm) occurred in 93 (55%) patients and was associated with the extent of femoral head involvement. Varus osteotomy was not associated with residual shortening. The patient's age at diagnosis did not affect the LLD at skeletal maturity. The strongest predictor of LLD was a lateral pillar classification of B/C or C (odds ratio, 3.5; 95% confidence interval, 1.39-8.79). Conclusions: The extent of femoral head involvement, but not the patient's age at diagnosis or sex or the treatment modality, can predict the LLD at skeletal maturity in patients with unilateral LCPD. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

Original languageEnglish
Pages (from-to)2570-2577
Number of pages8
JournalClinical Orthopaedics and Related Research
Volume471
Issue number8
DOIs
Publication statusPublished - 2013 Aug 1

Fingerprint

Legg-Calve-Perthes Disease
Leg
Pediatrics
Thigh
Osteotomy
Odds Ratio
Demography
Guidelines
Confidence Intervals

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Can residual leg shortening be predicted in patients with Legg-Calvé-Perthes' disease? Pediatrics. / Park, Kwang Won; Jang, Kyu Seon; Song, Hae Ryong.

In: Clinical Orthopaedics and Related Research, Vol. 471, No. 8, 01.08.2013, p. 2570-2577.

Research output: Contribution to journalArticle

@article{eb8ba15fa9af49059c96ac763c6aa392,
title = "Can residual leg shortening be predicted in patients with Legg-Calv{\'e}-Perthes' disease? Pediatrics",
abstract = "Background: Although Legg-Calv{\'e}-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified. Questions/purposes: We attempted to determine whether (1) the extent of femoral head involvement; (2) varus osteotomy; and (3) patient demographic characteristics are associated with LLD at skeletal maturity in patients with LCPD. Methods: We retrospectively reviewed the records of 168 skeletally mature patients with unilateral LCPD. The mean age at diagnosis was 7 years (range, 2-14 years). The extent of femoral head involvement was determined from the initial radiographs using the Herring lateral pillar and Catterall classifications. LLD was defined as shortening by ≥ 1.0 cm as measured from scanograms. The patient's sex and the treatment modalities used were also recorded. Results: LLD ranging from 10 to 38 mm (mean, 19 mm) occurred in 93 (55{\%}) patients and was associated with the extent of femoral head involvement. Varus osteotomy was not associated with residual shortening. The patient's age at diagnosis did not affect the LLD at skeletal maturity. The strongest predictor of LLD was a lateral pillar classification of B/C or C (odds ratio, 3.5; 95{\%} confidence interval, 1.39-8.79). Conclusions: The extent of femoral head involvement, but not the patient's age at diagnosis or sex or the treatment modality, can predict the LLD at skeletal maturity in patients with unilateral LCPD. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.",
author = "Park, {Kwang Won} and Jang, {Kyu Seon} and Song, {Hae Ryong}",
year = "2013",
month = "8",
day = "1",
doi = "10.1007/s11999-013-3009-4",
language = "English",
volume = "471",
pages = "2570--2577",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Can residual leg shortening be predicted in patients with Legg-Calvé-Perthes' disease? Pediatrics

AU - Park, Kwang Won

AU - Jang, Kyu Seon

AU - Song, Hae Ryong

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Background: Although Legg-Calvé-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified. Questions/purposes: We attempted to determine whether (1) the extent of femoral head involvement; (2) varus osteotomy; and (3) patient demographic characteristics are associated with LLD at skeletal maturity in patients with LCPD. Methods: We retrospectively reviewed the records of 168 skeletally mature patients with unilateral LCPD. The mean age at diagnosis was 7 years (range, 2-14 years). The extent of femoral head involvement was determined from the initial radiographs using the Herring lateral pillar and Catterall classifications. LLD was defined as shortening by ≥ 1.0 cm as measured from scanograms. The patient's sex and the treatment modalities used were also recorded. Results: LLD ranging from 10 to 38 mm (mean, 19 mm) occurred in 93 (55%) patients and was associated with the extent of femoral head involvement. Varus osteotomy was not associated with residual shortening. The patient's age at diagnosis did not affect the LLD at skeletal maturity. The strongest predictor of LLD was a lateral pillar classification of B/C or C (odds ratio, 3.5; 95% confidence interval, 1.39-8.79). Conclusions: The extent of femoral head involvement, but not the patient's age at diagnosis or sex or the treatment modality, can predict the LLD at skeletal maturity in patients with unilateral LCPD. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

AB - Background: Although Legg-Calvé-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified. Questions/purposes: We attempted to determine whether (1) the extent of femoral head involvement; (2) varus osteotomy; and (3) patient demographic characteristics are associated with LLD at skeletal maturity in patients with LCPD. Methods: We retrospectively reviewed the records of 168 skeletally mature patients with unilateral LCPD. The mean age at diagnosis was 7 years (range, 2-14 years). The extent of femoral head involvement was determined from the initial radiographs using the Herring lateral pillar and Catterall classifications. LLD was defined as shortening by ≥ 1.0 cm as measured from scanograms. The patient's sex and the treatment modalities used were also recorded. Results: LLD ranging from 10 to 38 mm (mean, 19 mm) occurred in 93 (55%) patients and was associated with the extent of femoral head involvement. Varus osteotomy was not associated with residual shortening. The patient's age at diagnosis did not affect the LLD at skeletal maturity. The strongest predictor of LLD was a lateral pillar classification of B/C or C (odds ratio, 3.5; 95% confidence interval, 1.39-8.79). Conclusions: The extent of femoral head involvement, but not the patient's age at diagnosis or sex or the treatment modality, can predict the LLD at skeletal maturity in patients with unilateral LCPD. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=84880253576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880253576&partnerID=8YFLogxK

U2 - 10.1007/s11999-013-3009-4

DO - 10.1007/s11999-013-3009-4

M3 - Article

C2 - 23616268

AN - SCOPUS:84880253576

VL - 471

SP - 2570

EP - 2577

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 8

ER -